Background
Since its emergence as a pathogen of interest, Campylobacter jejuni has consistently been listed as one of the leading causes of infectious diarrhea throughout the developed world [1, 2] , and is the most common antecedent infection associated with onset of the neurological disorder, Guillain-Barré Syndrome [3] . Despite more than thirty years of rigorous investigation, the exact mechanisms by which C. jejuni causes disease in humans have eluded researchers. Publications of the genome sequences of various strains of C. jejuni revealed a surprising absence of many genes encoding proteins required for signal transduction and gene regulation. Although C. jejuni regulates gene expression in response to oxidative stress, iron availability, pH, and growth temperature, it does so with only three sigma factors, six sensor histidine kinases, and eleven response regulators [4] [5] [6] [7] [8] [9] [10] [11] . This limited repertoire of regulatory elements and its overall lack of virulence factors has placed considerable importance on identifying novel mechanisms of pathogenesis and gene regulation to gain insight into the disease-causing mechanisms and capabilities of the organism in an effort to prevent and treat C. jejuni infections.
Observations reported by our laboratory and others have suggested an important role for the posttranscriptional regulator, CsrA (Carbon storage regulator), in the expression of several virulence-associated phenotypes in C. jejuni [12] [13] [14] [15] . In other bacteria, CsrA (or its ortholog RsmA) is a small, regulatory protein capable of both activating and repressing the translation of mRNA into protein (reviewed by Romeo [16] ). CsrA regulation is mediated by binding mRNA, often at or near the ribosome binding site (RBS), resulting in altered translation and stability of the message. CsrA, in turn, is regulated by the action of competitively binding two small, non-coding RNA molecules, csrB and csrC [16] [17] [18] [19] [20] , whose expression is activated by the BarA/UvrY two-component system [19, 21] . The CsrA pathway and the mechanism of regulation have been studied extensively in the γ-proteobacteria and further studies of the role of CsrA in various pathogens have extended its importance to the expression of virulence factors and the regulation of pathogenesis [22] [23] [24] [25] [26] . Despite these advances, very little is known about the mechanism of action of CsrA in the ε-proteobacteria. Examination of the C. jejuni genome [7, [27] [28] [29] suggests that this bacterium lacks several genes in the CsrA pathway, including apparent orthologs of the small RNA molecules csrB and csrC [30] , the barA/uvrY two-component signal transduction system, and csrD which is responsible for csrB and csrC turnover [31] . One report describing the role of CsrA in the gastric pathogen Helicobacter pylori indicated that CsrA was required for motility, survival under oxidative stress, and host colonization, and plays a role in the expression of several virulence and oxidative stress related proteins [23] . It was also suggested that the H. pylori ortholog was unable to function when exogenously expressed in E. coli because it failed to complement the glycogen accumulation phenotype of an E. coli csrA mutant [23] .
Considering these observations in H. pylori, the phenotypes of a C. jejuni csrA mutant, and the lack of knowledge concerning the functions of CsrA within the ε-proteobacteria, we examined the ability of C. jejuni CsrA to complement the phenotypes of an E. coli csrA mutant with the hope of gaining further insight into the molecular mechanism of C. jejuni CsrA. Phylogenetic comparison revealed that C. jejuni CsrA exhibits variability in amino acids that constitute the published RNA binding domains, as well as in other residues that are important for CsrA-mediated regulation in E. coli. Surprisingly, although the C. jejuni ortholog was unable to complement the glycogen accumulation phenotype of E. coli, successful rescue of several other E. coli mutant phenotypes was achieved, demonstrating both similarities and differences in the C. jejuni and E. coli Csr systems.
Methods

Bacterial strains and routine growth conditions
All bacterial strains used in this study are listed in Table 1 . Overnight cultures of E. coli strains were routinely carried out at 37°C on LB agar or in LB broth with shaking. One Shot® TOP10 chemically competent E. coli (Invitrogen, Carlsbad, CA) was used as a cloning host for TA-cloning procedures. E. coli MG1655 and TRMG1655 (csrA::Kan) were obtained from T. Romeo (University of Florida). When appropriate, E. coli strains were selected in LB medium using ampicillin (100 μg/ ml) or kanamycin (50 μg/ml). Cloned genes were induced by the addition of 0.002% L-arabinose to the growth media. C. jejuni strain 81-176 was grown on MH agar at 42°C under microaerophilic contitions (10% CO 2 , 10% O 2 , and 80% N 2 ) supplemented with 5% sheep's blood (Remel, Lenexa, KS).
Phylogenetic analyses
Phylogenetic comparison of CsrA orthologs was performed by neighbor joining using CLUSTALW [34] within the VectorNTI 7.1 program suite (Invitrogen, Carlsbad, CA). Accession numbers for CsrA proteins used in the comparisons are listed in Additional file 1: Table S1 . Bootstrapping (500 replicates) was performed to determine the statistical robustness of the clusters, and the percent of bootstraps that supported the clusters are indicated at each tree node ( Figure 1A ).
DNA and protein techniques
Genomic DNA from E. coli and C. jejuni strains for use in PCR amplification was purified using the Generation Capture Column Kit (Qiagen, Chatsworth, CA). The plasmids used in this study were extracted and purified using the QIAprep Spin Miniprep Kit (Qiagen). PCR reactions were carried out using the Expand High Fidelity PCR System (Roche, Mannheim, Germany). Primers for PCR ( and goat, anti-mouse IgG-horseradish peroxidase secondary antibody (Pierce). All kits used in this study were used according to the manufacturer's provided instructions.
Plasmid construction
Plasmids used in this study ( A Figure 1 C. jejuni CsrA is divergent from the E. coli ortholog, including in the RNA binding domains. A) CsrA orthologs from 20 diverse pathogenic and non-pathogenic bacterial species were aligned using CLUSTALW (neighbor joining). Numbers at tree nodes indicate the percent of bootstrap replicates that support the adjacent branches. Protein lengths (number of amino acids) are indicated to the right of each ortholog. Accession numbers for each protein are listed in Additional file 1: Table S1 . B) Alignment of the amino acid sequences of CsrA orthologs. Regions 1 and 2 of E. coli CsrA important for RNA binding [35] are indicated by boxes and other amino acid residues important for CsrA regulation are indicated by an asterisk (*). Red shading indicates amino acids that are identical to those of E. coli CsrA; purple shading indicates amino acids that are different from E. coli CsrA but identical within the C. jejuni-containing clade of Figure 1A . Amino acids within RNA binding sequences 1 and 2 of C. jejuni CsrA that are conservative substitutions compared to E. coli CsrA are underlined.
cloning the resulting amplicon into pBAD-TOPO. Both complementation vectors and empty pBAD-TOPO plasmid were then transformed into the E. coli csrA mutant strain, TRMG1655, and recovered on LB agar containing ampicillin and kanamycin. In all phenotypic testing, we performed arabinose titration experiments (including samples without added arabinose) to determine the dose-responsiveness of CsrA expression and complementation ability.
Glycogen accumulation
Glycogen accumulation was assessed using previously described methodologies [36] . Strains were grown at 37°C on Kornberg agar (1.10% K 2 HPO 4 , 0.85% KH 2 PO 4 , 0.6% yeast extract, 1.5% agar) with or without 2% (v:v) glycerol or 2% (w/v) sodium pyruvate; either glycerol or pyruvate was used as a carbon source as opposed to glucose due to the inhibitory effect of glucose on the araBAD promoter [37] . Briefly, cultures were spotted on agar in the presence or absence of a carbon source and grown overnight at 37°C. Following incubation the cultures were stained by exposure to iodine vapor by inverting the plates over iodine crystals.
Motility
Motility was quantitated as previously described [38] , inoculating semi-solid LB agar (0.35% agar) by stabbing with an inoculating needle dipped into overnight cultures and incubating for 14 hours at 30°C in a humidified incubator. After incubation, the diameter of the zone of motility was measured. Experiments were performed a minimum of three times with no fewer than three replicates per experiment.
Biofilm formation
Quantitative biofilm formation was assessed as previously described [33] . 
Electron microscopy
Cellular morphology was assessed by scanning electron microscopy (SEM). Briefly, cultures were grown at 37°C for 18 hours in the presence or absence of arabinose. The cultures were then pelleted, and washed twice and resuspended in PBS (pH 7.2) and submitted to the GHSU Electron Microsocopy Core Facility for SEM. Twelve fields of view for each sample were randomly chosen for analysis and imaged at 10000x magnification. The resulting micrographs where then analyzed to determine the average length of the cells from each culture (n ≥ 150). Cells that were obviously undergoing cell division or those which were positioned on an inappropriate axis for assessing length were excluded from analysis. The resulting data were then analyzed by one-way analysis of variables (ANOVA) to assess statistical significance among the strains and to rule out variation within the twelve fields of view for each strain as a source of error.
Statistical analysis
Results are presented as means ± standard error of means. Statistical significance was determined using ANOVA. P values of less than 0.05 were considered statistically significant.
Results
C. jejuni CsrA is evolutionarily divergent from E. coli CsrA and exhibits diversity in amino acid residues important for proper function in E. coli. Alignment of CsrA orthologs from a number of pathogenic and non-pathogenic bacteria ( Figure 1A) showed that CsrA proteins of the ε-proteobacteria C. jejuni and H. pylori clustered distantly from most of the more thoroughly characterized enterobacterial orthologs. Furthermore, ε-proteobacterial CsrA proteins were of a larger size (75-76 amino acids) compared to those most closely related to E. coli (61-67 amino acids). The size difference was largely attributable to an C-terminal extension in the larger CsrA proteins ( Figure 1B) . In contrast to the high degree of amino acid conservation of CsrA orthologs of E. coli, S. typhimurium, P. aeruginosa, V. cholerae, and L. pneumophila, the CsrA proteins of C. jejuni and H. pylori exhibited substantial divergence from E. coli CsrA throughout ( Figure 1B) . This diversity was also apparent in two domains that were shown to be critical for RNA binding in E. coli CsrA [35] . In the most N-terminal RNA binding region (amino acids 2-7), C. jejuni CsrA shared four of six identical (two of six similar) amino acids with E. coli CsrA ( Figure 1B) . The C-terminal RNA binding region (amino acids 40-47) showed greater diversity, with only two of eight identical (three of eight similar) amino acids. Two additional amino acids that were shown to be important for regulation by E. coli CsrA (positions 19 and 35, marked by asterisks in Figure 1B ) also were not conserved in C. jejuni CsrA. Together, these differences suggested the possibility that C. jejuni CsrA may regulate protein expression by binding to somewhat different RNA sequences than those bound by E. coli CsrA.
C. jejuni CsrA is unable to repress E. coli glycogen biosynthesis
CsrA regulates E. coli glycogen biosynthesis via its effect on the genes in the glgCAP operon [12] , and an E. coli csrA mutant accumulates significantly more glycogen than wild-type cells (Figure 2) . A previous report indicated that the H. pylori ortholog of CsrA was unable to complement the glycogen biosynthesis phenotype of the E. coli csrA mutant [23] . Considering the close phylogenetic relationship between C. jejuni and H. pylori, we sought to determine the complementation potential of the Campylobacter ortholog for this phenotype. We expressed CsrA proteins from C. jejuni and E. coli (control) in an E. coli csrA mutant under the control of the arabinose-inducible araBAD promoter and examined glycogen accumulation on Kornberg agar in the presence of both glycerol ( Figure 2 ) and pyruvate (data not shown). Glycerol and pyruvate were used as carbon sources to drive glycogen biosynthesis rather than glucose due to the inhibitory affect of glucose on the araBAD promoter [37] . In the presence of arabinose, we found that expression of C. jejuni CsrA in the E. coli mutant strain failed to repress gluconeogenesis, resulting in glycogen staining similar to that of the mutant strain harboring the vector alone. Expression of E. coli CsrA restored wild-type levels of glycogen staining, as expected, and the presence of the vector alone had no effect on glycogen accumulation in the wild-type strain. Expression of both orthologs of CsrA was confirmed by western blot analysis ( Figure 2) .
Expression of C. jejuni CsrA rescues the motility defect of an E. coli csrA mutant
In E. coli, CsrA regulates motility by activating the regulatory operon flhDC [38] , via stabilization of the flhDC transcript when post-transcriptionally bound by CsrA in vivo. In the absence of CsrA, E. coli cells exhibit a four-fold decrease in FlhDC expression resulting in a loss of motility. We compared the motility of wild-type and csrA mutant E. coli containing the vector alone to that of the csrA mutant strain expressing CsrA from E. coli or C. jejuni (Figure 3 ). We found that the C. jejuni ortholog significantly (p<0.0001) rescued the motility defect in a manner similar to that of E. coli CsrA (p<0.0001). Neither ortholog of CsrA successfully complemented motility in the absence of arabinose (data not shown) and the vector had no effect on motility in either the wild-type or mutant compared to the parent strains (data not shown). Western blots were used to confirm CsrA expression ( Figure 3 on the biofilm polysaccharide adhesin poly-N-acetylglucosamine (PGA) [15] . To determine the ability of C.jejuni CsrA to regulate biofilm formation in E. coli, we grew wild-type, mutant, and complemented strains statically, in 96-well polystyrene microtiter plates or in polystyrene culture tubes for 24 hours at 26°C and stained biofilms with crystal violet as previously described (Figure 4 ). As expected, the E. coli csrA mutant produced excess biofilm when compared to the wild-type; biofilm formation of neither the wild-type nor the mutant strains was affected by the presence of the vector (data not shown).
As expected, E. coli CsrA complemented the mutant biofilm phenotype. Similarly, C. jejuni CsrA expression significantly reduced biofilm formation in the mutant to levels similar to that of wild-type (p<0.001). CsrA expression was confirmed by western blots (Figure 4 ).
C. jejuni CsrA expression restores the E. coli csrA mutant to wild-type morphology
We sought to examine reported morphological differences between the wild-type E. coli and csrA mutant strains and determine the capability of C. jejuni CsrA to complement the observed difference in cell size. We grew wild-type and mutant strains containing the vector alone and mutant strains containing the pBADcsrA EC and pBADcsrA CJ complementation vectors in the presence or absence of arabinose and measured the length of the cells ( Figure 5 ). When grown in the absence of arabinose, we observed the reported elongated phenotype of the csrA mutant [36] which was unaffected by the presence of the vector. Interestingly, in the presence of arabinose, we observed a substantial increase in the length of wild type cells ( Figure 5A ), which was not evident in the mutant ( Figure 5B ; p<0.001). Expression of CsrA from both E. coli and C. jejuni ( Figures 5C and 5D , respectively) significantly returned the mutant to the wild type dimensions (p<0.001). Western blot analysis confirmed expression of CsrA in the complemented mutant strains (data not shown).
Discussion
Presently, studies from C. jejuni and the closely related gastric pathogen, H. pylori, report mostly the phenotypic effects of csrA mutation [13, 23] . Furthermore, in C. jejuni as well as H. pylori the small RNA molecules either unidentified or absent [7, [27] [28] [29] [30] 39] . This suggests that the molecular mechanisms may be somewhat different than those in E. coli. In this study, we sought to determine the capability of the C. jejuni CsrA ortholog to complement the phenotypes of an E. coli csrA mutant to gain insight into the mechanisms of C. jejuni CsrA function. The E. coli csrA mutation has several phenotypes that can be used as tools for determining the capability of CsrA orthologs from other bacteria to complement the well-characterized E. coli strain. For instance, mutation of csrA in E. coli alters glycogen biosynthesis, biofilm accumulation, motility, and cellular morphology, as well as several other cellular processes. Mercante and colleagues [35] used the glycogen, biofilm, and motility phenotypes as a means to analyze the effects of comprehensive alanine-scanning mutagenesis of E. coli CsrA. In that study, the authors were able to identify which amino acids were most important for regulating glycogen biosynthesis, biofilm production, and motility, while also defining two regions of CsrA that are responsible for RNA binding.
When we compared representative CsrA orthologs from other bacteria, we found that C. jejuni CsrA is considerably divergent, as it clustered distantly from the E. coli ortholog. In part this is due to the significantly larger size of CsrA orthologs in the C. jejuni cluster (75-76 amino acids) as compared to the E. coli cluster (61-67 amino acids, Figure 1A ). Considering the phylogenetic divergence of C. jejuni CsrA, we also examined the amino acid sequences of several CsrA orthologs of the pathogenic bacteria represented in Figure 1A to investigate the conservation of individual residues known to be important for the function of E. coli CsrA [35] , and found that C. jejuni CsrA is considerably divergent in several key amino acid residues. Variability is found in both RNA binding domains, region 1 and region 2, although greater variation is found in region 2. The first region, residues 2-8, contains only two conservative substitutions (T5S and R7K) while the other four residues are identical. RNA binding region 2 is highly variable consisting of two residues that are identical to E. coli (R44 and E46), three similar amino acids (V40L, V42I, and I47L), and three non-conservative substitutions (S41M, H43L, and E45K). Between the defined binding regions, there were two non-conservative substitutions (T19E and N35E) we found to be particularly interesting because of their reported ability to improve the regulatory functions of CsrA in E. coli [35] . Presently, we are not able to draw any specific conclusions as to the significance of the individual amino acid substitutions in C. jejuni as compared to E. coli; however, it is likely that this divergence from E. coli plays a role in the ability of the C. jejuni ortholog to bind to E. coli targets appropriately.
In several studies, researchers characterizing the CsrA orthologues of different bacteria have used the glycogen biosynthesis phenotype of the E. coli csrA mutant to determine the functional similarities. One such study, of particular interest to our laboratory, reported that the H. pylori ortholog of CsrA would not functionally complement the E. coli mutant as it failed to repress glycogen biosynthesis [23] . It is likely that the H. pylori CsrA complementation failure was due to differences in the functional mechanism of ε-proteobacterial CsrA, however, this may have been specific to the two CsrAbinding sites of the glgCAP mRNA but not to other CsrA targets. To test this for C. jejuni CsrA, we examined the ability of CsrA CJ to complement multiple E. coli csrA mutant phenotypes. We first expressed the C. jejuni * * ortholog in the E. coli csrA mutant and assessed its ability to repress glycogen biosynthesis under gluconeogenic conditions. Similar to H. pylori CsrA, the C. jejuni CsrA ortholog was incapable of repressing glycogen accumulation in the E. coli csrA mutant. We next examined the ability of the C. jejuni protein to complement the motility, biofilm accumulation, and cellular morphology phenotypes of the E. coli mutant as well. As with glycogen biosynthesis, CsrA-mediated regulation of biofilm formation in E. coli is based on repression of a synthetic pathway, in this case the pgaABCD operon [15] . However, CsrA mediated expression of PgaABCD appears to be more complicated than that of glycogen biosynthesis, as it was reported that the mRNA leader sequence of the operon contains as many as six CsrA binding sites compared to the two binding sites observed on the glg leader sequence. Regardless of the complexity of the molecular mechanism of CsrA regulation of PGA we found that, when expressed in the E. coli csrA mutant, C. jejuni CsrA successfully complemented the biofilm formation phenotype (p<0.001).
Considering that the regulation of the glg and pga operons are both examples of CsrA-mediated repression of a biosynthetic pathway, we wanted to determine the ability of C. jejuni CsrA to substitute for its E. coli ortholog when the activation of gene expression is required. Wei and colleagues demonstrated that CsrA is a potent activator of flhDC expression and is therefore required for synthesis of the E. coli flagellum [38] . When we expressed C. jejuni CsrA within the non-motile E. coli csrA mutant the phenotype was completely rescued (p<0.001) suggesting that the C. jejuni ortholog is capable of promoting FlhDC expression.
Finally, we assessed the ability of C. jejuni CsrA to rescue an uncharacterized phenotype such as the altered cellular morphology of the E. coli csrA mutant. When CsrA was discovered, Romeo and colleagues reported that the csrA mutant displayed a greater cellular size as compared to the wild type, which was most obvious in early stationary phase [40] . This phenotype was explained as a possible indirect effect of endogenous glycogen accumulation. When we grew the wild type, csrA mutant, and complemented E. coli strains in LB media and observed their morphology via scanning electron microscopy, we observed a modest but significant decrease in the size of the mutant as compared to the wild-type as reported by Romeo [36] in the absence of arabinose; however, in the presence of arabinose we observed a marked decrease in the size of the mutant as compared to the wild type (p<0.001). This decrease in size was complemented by both orthologs of CsrA (p<0.001). As Romeo suggested that the size differences between the mutant and wild type may be due to the role of endogenous glycogen cellular morphology, it is possible that the presence of arabinose used for protein expression may play a separate metabolic role within the cell leading to the observed phenotype.
A number of studies have shown that regulation of mRNA targets by E. coli CsrA is complex [12, 15, 35, 41] . Mercante et al. [41] showed that proper regulation depends on simultaneous binding of E. coli CsrA to multiple sites on target mRNAs, involving both of the RNAbinding surfaces of CsrA, using a multi-site bridging mechanism, and also the formation of higher order ribonucleoprotein complexes. Therefore, it is possible that the lack of regulation of the E. coli glg genes by C. jejuni CsrA is not due just to simple binding of one glg site vs. another, but rather due to changes in the dynamics (i.e. not 'all or nothing') of one or more of these bridging or ribonucleoprotein formation processes. For example, even moderately decreased affinity of C. jejuni CsrA for one of the glg sites may inhibit the formation of multisite bridges and ribonucleoprotein complexes and therefore not result in productive regulation.
Finally, the binding of some but not all E. coli CsrA binding sites by C. jejuni CsrA infers that εproteobacterial CsrA binding sites are likely to show at least subtle differences from such sites in E. coli. It further underscores that predictive algorithms based solely or primarily on E. coli CsrA binding sites may be problematic for identifying CsrA binding sites in εproteobacteria and other divergent bacteria (Figure 1 ) [30] , and that experimental approaches are preferable (such studies are ongoing in our lab).
Conclusions
This study has shown that CsrA from the ε-proteobacteria C. jejuni exhibits substantial sequence divergence compared to previously studied CsrA regulators from other bacteria, including in the RNA-binding domains. The ability of C. jejuni CsrA to complement some, but not all, phenotypes of an E. coli csrA mutant demonstrates both conservation and divergence of function, and suggests that the C. jejuni ortholog may have differences in binding specificity relative to its E. coli counterpart. Studies to define the C. jejuni CsrA RNA binding site are ongoing. phylogenetic analyses, and performed critical revisions of the manuscript. Both authors have read and approved the final manuscript.
